Evaluation the effect of sucralfate 15% mouthwash for Prevention and treatment mouth sores induced by chemotherapy drugs
Phase 2
- Conditions
- 5-fluorouracil induced oral mucositis.Disease of oral cavity : stomatitisk00-k14
- Registration Number
- IRCT201107053014N4
- Lead Sponsor
- Vice chancellor for research, Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Cancer patients between 18-70 years receiving 5-fluorouracil containing chemotherapy regimens.
Exclusion criteria: Sucralfate intolerance or inappropriate use of the mouth wash
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mouth sores. Timepoint: every 3 days. Method of measurement: Use of the WHO table and ruler.
- Secondary Outcome Measures
Name Time Method Pain. Timepoint: Before and after 1 months of intervention. Method of measurement: Visual analoug scale (VAS).;Dysphagia to liquids. Timepoint: Before and after 2 months of intervention. Method of measurement: Ask a question.;Dysphagia to solids. Timepoint: weekly. Method of measurement: Ask a question.;Bleeding. Timepoint: Before and after 2 months of intervention. Method of measurement: Ask a question.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does 15% sucralfate mouthwash target in 5-FU-induced oral mucositis (IRCT201107053014N4)?
How effective is 15% sucralfate mouthwash versus benzydamine or amifostine for 5-FU-induced oral mucositis (IRCT201107053014N4)?
Which biomarkers predict response to 15% sucralfate mouthwash in 5-fluorouracil-induced oral mucositis (IRCT201107053014N4)?
What are the adverse event profiles and management strategies for 15% sucralfate mouthwash in 5-FU-induced oral mucositis (IRCT201107053014N4)?
Are there combination therapies involving sucralfate and other cytoprotective agents for 5-fluorouracil-induced oral mucositis (IRCT201107053014N4)?